Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Soligenix Inc (NASDAQ:SNGX)

3.08
Delayed Data
As of Apr 28
 -0.24 / -7.23%
Today’s Change
1.90
Today|||52-Week Range
9.00
+36.89%
Year-to-Date
No recent news for Soligenix Inc.

Today’s Trading

Previous close3.32
Today’s open3.50
Day’s range2.87 - 3.50
Volume336,633
Average volume (3 months)434,738
Market cap$16.9M
Dividend yield--
Data as of 3:59pm ET, 04/28/2017

Growth & Valuation

Earnings growth (last year)+55.33%
Earnings growth (this year)--
Earnings growth (next 5 years)+1.00%
Revenue growth (last year)+19.16%
P/E ratioNM
Price/Sales0.77
Price/Book2.28

Competitors

 Today’s
change
Today’s
% change
VTGNVistaGen Therapeutic...+0.01+0.51%
PZRXPhaseRx Inc+0.14+11.34%
APTOAptose Biosciences I...-0.00-0.02%
CLSNCelsion Corp+0.00+0.74%
Data as of 3:59pm ET, 04/28/2017

Financials

Next reporting dateMay 5, 2017
EPS forecast (this quarter)-$0.17
Annual revenue (last year)$10.4M
Annual profit (last year)-$3.2M
Net profit margin-31.06%

Profile

Sector
Health Technology
Industry
Biotechnology
Chairman, President &
Chief Executive Officer
Christopher J. Schaber
Chief Financial Officer &
Senior Vice President
Karen R. Krumeich
Corporate headquarters
Princeton, New Jersey

Forecasts